Free Trial

Obesity Drug Boom, Split Make This Stock a Heavy Bargain

Key Points

  • Rapidly growing demand for Novo Nordisk’s GLP-1 diabetes and obesity treatments are fattening up its financial results.
  • Last month, the company completed a 2-for-1 stock split that put its price under $100.
  • Management raised full-year sales growth outlook to 27% to 33%, reflecting the company's massive market share in a pair of fast-growth markets.
  • Five stocks we like better than Novo Nordisk A/S.

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should You Invest $1,000 in Novo Nordisk A/S Right Now?

Before you consider Novo Nordisk A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novo Nordisk A/S wasn't on the list.

While Novo Nordisk A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Novo Nordisk A/S (NVO)
4.7239 of 5 stars
$69.14+1.4%2.36%21.03Hold$135.00
Eli Lilly and Company (LLY)
4.9796 of 5 stars
$733.71-1.8%0.82%62.76Moderate Buy$1,011.37
Walmart (WMT)
4.33 of 5 stars
$97.15-0.7%0.97%40.36Moderate Buy$104.94
Mondelez International (MDLZ)
4.5545 of 5 stars
$65.55-0.5%2.87%19.18Moderate Buy$70.55
Nestlé (NSRGY)
1.4703 of 5 stars
$106.12+1.2%2.05%N/AHold$91.00
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines